Frontiers in Immunology (Oct 2022)

Progress in the application of body fluid and tissue level mRNAs-non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus

  • Jiabin Liang,
  • Jiabin Liang,
  • Fangmei Xie,
  • Jie Feng,
  • Chen Huang,
  • Jian Shen,
  • Zeping Han,
  • Wenfeng Luo,
  • Jinhua He,
  • Hanwei Chen,
  • Hanwei Chen

DOI
https://doi.org/10.3389/fimmu.2022.1020891
Journal volume & issue
Vol. 13

Abstract

Read online

The diagnosis and differential classification of systemic lupus erythematosus (SLE) is difficult, especially in patients with early-onset SLE who are susceptible to systemic multi-organ damage and serious complications and have difficulties in individualized treatment. At present, diagnosis is based mainly on clinical manifestations and the detection of serological antinuclear antibodies. The pathogenesis of SLE involves multiple factors, is clinically heterogeneous, and lacks specific biomarkers. Therefore, it is necessary to identify new biomarkers for the diagnosis and subtype classification of SLE. Non-coding RNAs (ncRNAs) are composed of microRNAs, long non-coding RNAs, small nucleolar RNAs, circular RNAs, and transfer RNAs. They play an important role in the occurrence and development of diseases and are used widely in the early diagnosis and prognosis of autoimmune diseases. In this review, we focus on the research progress in the diagnosis and prognostic assessment of SLE using humoral to tissue level ncRNAs.

Keywords